×
About 2,788 results

ALLMedicine™ Prostatic Hyperplasia Center

Research & Reviews  717 results

Evaluation of efficacy and safety of improved transurethral plasma kinetic enucleation ...
https://doi.org/10.1177/03000605211060890
The Journal of International Medical Research; Meng Q, Li J et. al.

Dec 2nd, 2021 - This prospective study aimed to evaluate the safety of improved transurethral plasma kinetic enucleation of the prostate (iTUPKEP) in the perioperative period in high-risk patients with benign prostatic hyperplasia (BPH) and coronary artery diseas...

Assessment of Frailty and Association With Progression of Benign Prostatic Hyperplasia ...
https://doi.org/10.1001/jamanetworkopen.2021.34427
JAMA Network Open; Bauer SR, Walter LC et. al.

Nov 25th, 2021 - Benign prostatic hyperplasia (BPH) in older men can cause lower urinary tract symptoms (LUTS), which are increasingly managed with medications. Frailty may contribute to both symptom progression and serious adverse events (SAEs), shifting the bala...

Tamsulosin facilitates depressive-like behaviors in mice: Involvement of endogenous glu...
https://doi.org/10.1016/j.brainresbull.2021.11.005
Brain Research Bulletin; Holanda VAD, Oliveira MC et. al.

Nov 20th, 2021 - The benign prostatic hyperplasia (BPH) is the main source of lower urinary tract symptoms. The BPH is a common age-dependent disease and tamsulosin is an α1-adrenoceptor blocker widely prescribed for BPH. Beyond the common adverse effects of tamsu...

Holmium laser enucleation versus bipolar resection in the management of large-volume be...
https://doi.org/10.1111/iju.14737
International Journal of Urology : Official Journal of Th... Habib E, Abdallah MF et. al.

Nov 18th, 2021 - To compare the mid-term safety and efficacy of holmium laser enucleation of the prostate versus bipolar transurethral resection of the prostate in the management of large-volume benign prostatic hyperplasia. From December 2016 to March 2018, patie...

see more →

Guidelines  4 results

Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: ...
https://doi.org/10.1097/JU.0000000000002183
The Journal of Urology; Lerner LB, McVary KT et. al.

Aug 14th, 2021 - Benign prostatic hyperplasia (BPH) is a histologic diagnosis describing proliferation of smooth muscle and epithelial cells within the prostatic transition zone. The prevalence and severity of lower urinary tract symptoms (LUTS) in aging men are p...

Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hype...
https://doi.org/10.1097/JU.0000000000001298
The Journal of Urology; Parsons JK, Dahm P et. al.

Jul 24th, 2020 - The AUA Guideline panel provides evidence-based recommendations for the surgical management of male lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). The Panel amended the Guideline in 2020 to reflect additional ...

Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hype...
https://doi.org/10.1097/JU.0000000000000319
The Journal of Urology; Foster HE, Dahm P et. al.

May 7th, 2019 - Male lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) is common in men and can have negative effects on quality of life (QoL). It is the hope that this Guideline becomes a reference for effective evidence-based s...

Korean clinical practice guideline for benign prostatic hyperplasia.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778754
Investigative and Clinical Urology; Yeo JK, Choi H et. al.

Mar 12th, 2016 - In 2014, the Korean Urological Association organized the Benign Prostatic Hyperplasia Guideline Developing Committee composed of experts in the field of benign prostatic hyperplasia (BPH) with the participation of the Korean Academy of Family Medi...

see more →

Drugs  353 results see all →

News  39 results

AUA Updates LUTS/BPH Guidelines on Initial Workup, Surgery
https://www.medscape.com/viewarticle/957952

Sep 1st, 2021 - The American Urological Association (AUA) has updated its guidelines on managing male lower urinary tract symptoms (LUTS) attributed to benign prostatic hyperplasia (BPH). The updates, the first since 2010, were summarized in the Journal of Urolog...

Complication Rates After Surgery for BPH: Real-World Data
https://www.medscape.com/viewarticle/954693

Jul 13th, 2021 - For patients with benign prostatic hyperplasia (BPH), there are several options when to comes to surgical treatment. A comparison of real-world outcomes reveals significant differences in postprocedural complication and re-treatment rates. The res...

Photoselective Vaporization Safely Alleviates Refractory LUTS in Prostate Cancer Patients
https://www.medscape.com/viewarticle/946349

Feb 25th, 2021 - NEW YORK (Reuters Health) - Photoselective vaporization of the prostate can provide relief from refractory lower-urinary-tract symptoms (LUTS) resulting from benign prostatic hyperplasia (BPH) in prostate cancer patients managed by active surveill...

Prostate Drugs Tied to Lower Risk for Parkinson's
https://www.medscape.com/viewarticle/945551

Feb 9th, 2021 - Certain drugs currently used to treat benign prostatic hyperplasia (BPH) may provide neuroprotection and delay or prevent the onset of Parkinson's disease, new research suggests. Treatment of BPH with terazosin (Hytrin), doxazosin (Cardura), or al...

Fast Five Quiz: Benign Prostatic Hyperplasia Key Aspects
https://reference.medscape.com/viewarticle/943651

Jan 12th, 2021 - Benign prostatic hyperplasia (BPH) is present in as many as 60% of men in their 60s and 90% of men older than 70 years. BPH describes nonmalignant prostate tissue growth and commonly causes lower urinary tract symptoms (LUTS). Not all men with BPH...

see more →

Patient Education  2 results see all →